Sangamo Therapeutics
SGMO
#8766
Rank
S$0.21 B
Marketcap
S$0.62
Share price
-4.11%
Change (1 day)
-76.11%
Change (1 year)

Earnings for Sangamo Therapeutics (SGMO)

Earnings in 2025 (TTM): -S$0.15 Billion

According to Sangamo Therapeutics 's latest financial reports the company's current earnings are S$32.87 Million. In 2024 the company made an earning of -S$0.13 Billion, an increase over its 2023 earnings that were of -S$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sangamo Therapeutics from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.15 Billion12.72%
2024 -S$0.13 Billion-17.27%
2023 -S$0.16 Billion-40.88%
2022 -S$0.27 Billion9.79%
2021 -S$0.24 Billion41.52%
2020 -S$0.17 Billion23.17%
2019 -S$0.14 Billion36.33%
2018 -S$99.9 Million36.89%
2017 -S$72.98 Million-22.32%
2016 -S$93.96 Million54.86%
2015 -S$60.68 Million75.62%
2014 -S$34.55 Million0.13%
2013 -S$34.51 Million
2011 -S$46.39 Million43.66%
2010 -S$32.29 Million28.52%
2009 -S$25.13 Million-23.55%
2008 -S$32.87 Million2.45%
2007 -S$32.08 Million19.5%
2006 -S$26.85 Million50.78%
2005 -S$17.81 Million75%
2004 -S$10.18 Million-33.25%
2003 -S$15.24 Million-62.27%
2002 -S$40.4 Million102.82%
2001 -S$19.92 Million23.21%
2000 -S$16.17 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.80 B-9,167.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
S$0.16 B-219.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.67 B-7,661.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.46 B-1,846.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
-S$0.97 Billion 582.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$41.94 B-29,814.01%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$0.87 B-723.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.89 B-21,278.43%๐Ÿ‡บ๐Ÿ‡ธ USA